Your shopping cart is currently empty

Myosin light chain kinase fragment 11-19 amide (MLCK(11-19) amide) acts as a substrate-specific peptide inhibitor of MLCK and inhibits hypotonicity-induced Ca2+ entry, with applications in human cervical cancer research [1] [2].

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 5 mg | Inquiry | Inquiry | Inquiry | |
| 50 mg | Inquiry | Inquiry | Inquiry |
| Description | Myosin light chain kinase fragment 11-19 amide (MLCK(11-19) amide) acts as a substrate-specific peptide inhibitor of MLCK and inhibits hypotonicity-induced Ca2+ entry, with applications in human cervical cancer research [1] [2]. |
| In vitro | Myosin light chain kinase fragment 11-19 amide (5 μM) reduces the amplitude and slows the activation kinetics of noradrenaline-induced non-selective cation current (I_cat) in rabbit portal vein myocytes [1]. |
| Synonyms | MLCK(11-19) amide |
| Molecular Weight | 987.16 |
| Formula | C40H78N18O11 |
| Cas No. | 119386-39-9 |
| Smiles | [C@@H](NC([C@@H](NC([C@H](CCCCN)N)=O)CCCCN)=O)(C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N)=O)CO)=O)[C@@H](C)O)=O)C)=O)CCCNC(=N)N)=O)C)=O)C)=O)CCCNC(=N)N |
| Sequence | H-DL-Lys-DL-Lys-DL-Arg-DL-Ala-DL-Ala-DL-Arg-DL-Ala-DL-xiThr-DL-Ser-NH2 |
| Sequence Short | KKRAARAXS |
| Storage | keep away from moisture | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 μL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.